Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 28, 2021; 27(36): 6053-6063
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6053
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6053
HBeAg positive | HBeAg negative | HBsAg negative | |
HBV infection (normal ALT) | High HBsAg | Low HBsAg | HBcAb-positive with/without positive HBsAb |
HBV DNA > 107 IU/mL | HBV DNA < 2000 IU/mL | HBV DNA usually undetectable | |
None/minimal liver disease | No liver disease | No liver disease | |
Old terminology: Immune-tolerant | Old terminology: Inactive carrier/immune control | Old terminology: Occult HBV infection | |
Hepatitis B (abnormal ALT) | High or intermediate HBsAg | Intermediate HBsAg | |
HBV DNA 104-107 IU/mL | HBV DNA > 2000 IU/mL | ||
Moderate to severe liver disease | Moderate to severe liver disease | ||
Old terminology: immune-active | Old terminology: immune escape |
- Citation: Stinco M, Rubino C, Trapani S, Indolfi G. Treatment of hepatitis B virus infection in children and adolescents. World J Gastroenterol 2021; 27(36): 6053-6063
- URL: https://www.wjgnet.com/1007-9327/full/v27/i36/6053.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i36.6053